ROVI — Laboratorios Farmaceuticos Rovi Share News
0.000.00%
- €2.95bn
- €2.94bn
- €743.48m
Spanish stocks - Factors to watch on June 19
Rovi rises after Q1 beat, new grant announcement
Spanish stocks - Factors to watch on May 8
Brief: Rovi To Receive 36.3 Mln Euro Grant For Research Into Prolonged-Release Drugs And New Sterile Filling Technologies
Brief: Rovi Sees 2025 Operating Revenue To Decrease By Mid-Single-Digit Percentage Vs 2024
Brief: ROVI Q1 Revenue EUR 154.9 Million
Spanish stocks - Factors to watch on March 25
Brief: Rovi Sees 2030 CDMO Revenue At About 700 Mln Euros
Spanish stocks - Factors to watch on March 5
Spanish stocks - Factors to watch on Feb 25
Brief: Rovi To Propose Distribution Of Dividend Charged To Results Of FY 2024 For 0.9351 Gross Eur/Shr
Brief: Rovi FY Net Profit At 136.9 Mln Euros
Brief: Rovi Maintains Its 2025 Guidance
Brief: Rovi FY Net Profit At 136.9 Mln Euros
Brief: ROVI FY Revenue EUR 763.7 Million Vs. IBES Estimate EUR 766 Million
Rovi 2024 EBITDA outlook misses market consensus, shares plummet
Spanish stocks - Factors to watch on Feb 7
Brief: Rovi Sees Its 2024 EBITDA Levels To Be Lower Than Market Consensus
Spanish stocks - Factors to watch on Dec 6